Increasing the expressions of either CEACAM1 or CEACAM5, the ligand for NK CEACAM1, did not affect the killings against cancer cells by CD56+CD16+ NK cells, since these cells do not express CEACAM1 (Figure 6B). Here, CEACAM5 is linked to cancer.